Goldman SACHS & Co. LLC, 10% Owner at VIVEVE MEDICAL, INC. (VIVE), sold 19,416 shares at $6.90 ($109K) on 2019-09-20, disclosed to the SEC on 2019-10-23.
Open-market sale of $109k VIVE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.90 | 1,658 | $11K | 10.5% |
| 2 | $6.05 | 800 | $5K | 4.5% |
| 3 | $5.57 | 800 | $4K | 4.1% |
| 4 | $5.62 | 10,799 | $61K | 55.8% |
| 5 | $5.10 | 5,359 | $27K | 25.1% |
| Total | $5.60 avg | 19,416 |
| $109K |
| 100% |
| Filing → |
| NCAC | BUY | 2023-03-08 | $0 | — | Filing → |
| NCAC | SELL | 2023-03-08 | $40K | — | Filing → |
| FLYW | SELL | 2022-11-17 | $15.0M | — | Filing → |